ZFGN

Zafgen, Inc. News Headlines

$40.36
*  
1.395
3.58%
Get ZFGN Alerts
*Delayed - data as of Jan. 26, 2015  -  Find a broker to begin trading ZFGN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ZFGN Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Zafgen Prices Public Offering Of 3.9 Mln Shares At $35.00 Per Share
1/22/2015 11:38:00 PM - RTT News


Forget Pills! Could This Device Put an End to Obesity in America?
1/17/2015 7:21:03 AM - Motley Fool


Zafgen (ZFGN) Enters Overbought Territory - Tale of the Tape
1/15/2015 10:02:11 AM - Zacks.com


Will Zafgen (ZFGN) Continue to Surge Higher? - Tale of the Tape
12/24/2014 9:33:27 AM - Zacks.com


Novo Nordisk Enters Anti-Obesity Space With New FDA Approval
12/24/2014 7:46:00 AM - Seeking Alpha


Zafgen (ZFGN) Shows Strength: Stock Moves 9.8% Higher - Tale of the Tape
12/23/2014 8:51:00 AM - Zacks.com


This Growing Concern Accounts For Nearly 500,000 Cancer Cases Each Year
12/7/2014 1:51:02 PM - Motley Fool


Zafgen (ZFGN) Shares March Higher, Can It Continue? - Tale of the Tape
11/26/2014 8:30:27 AM - Zacks.com


Janssen Is Working Its Way Toward Anti-Obesity
11/17/2014 5:14:00 PM - Seeking Alpha


Could Arena Pharmaceuticals Inc. Be Running Out of Money?
10/22/2014 7:20:02 AM - Motley Fool


What To Watch For As Orexigen's Launch Approaches
10/16/2014 8:05:00 AM - Seeking Alpha


Diabetes/Alzheimer's biotech Vitae Pharmaceuticals sets terms for $60 million IPO
9/8/2014 5:33:56 PM - Renaissance Capital


Zafgen's Beloranib Gets Orphan Drug Status in the EU - Analyst Blog
7/14/2014 10:40:00 AM - Zacks.com


InsiderInsights Daily Round Up: 6/23/14
6/24/2014 12:10:00 AM - Seeking Alpha


U.S. IPO Pricing Recap: Count Surpasses 2011 And 2012 As Markit And 9 Others Go Public
6/23/2014 2:40:00 PM - Seeking Alpha


IPO Lookout: IPOs Up Double Digits On The Week
6/23/2014 11:35:09 AM - Benzinga


The Anti-Obesity Space Is Not As Simple As Some Think
6/20/2014 11:34:00 AM - Seeking Alpha


Sector Update: Healthcare Stocks Close With Narrow Gains; Zafgen Jumps Nearly 23% After Pricing Upsized IPO
6/19/2014 3:01:17 PM - MT Newswires


Sector Update: Healthcare
6/19/2014 2:59:54 PM - MT Newswires


IPO Preview: Zafgen
6/19/2014 2:05:00 AM - Seeking Alpha


Zafgen prices upsized IPO at $16, the high end of the range
6/18/2014 5:12:35 PM - Renaissance Capital


12 U.S. IPOs Planned For The Week Of June 16
6/17/2014 7:15:00 AM - Seeking Alpha


Obesity biotech Zafgen sets terms for $75 million IPO
6/5/2014 6:23:45 PM - Renaissance Capital


U.S. IPO Recap: The IPO Market Finds A Clearing Price
4/22/2014 12:31:00 PM - Seeking Alpha